Gene Query: MYO6

Dataset Description Geneva Score
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 155.41
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 155.41
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 108.07
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 81.96
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 51.68
Pharmacologic inhibition of STAT5 in AML 50.57
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 49.57
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 49.43
RNA-seq analyses of human prostate cancer cells 47.29
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 47.13
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 43.41
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 43.41
A role for ZNF598 in post-transcriptional gene regulation 41.07
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 40.73
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 39.36
CD86 regulates a pro-survival signal in myeloma cells 38.28
Genes significantly down or Up-regulated upon RNF219 knockdown 37.92
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 37.5
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 35.19
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 33.6
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 33.6
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 32.97
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 32.97
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 32.97
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 32.65
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 32.35
Landscape of H3K4me3 in human CD19 cells 31.79
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 31.72
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 30.69
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 30.49
Lipid degradation promotes prostate cancer cell survival 29.74
The role of FAM46C in myeloma cells 28.39
The role of FAM46C in myeloma cells [sequencing] 28.39
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 28.17
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 27.57
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 27.56
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 27.41
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 27.26
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 27.09
A prostate cancer chromatin interaction map 26.95
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 26.39
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 26.16
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 26.16
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 25.81
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 25.65
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 25.65
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 25.19
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 25.11
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 24.49
Genome wide expression change in LCC2 and MCF-7 cells 24.04
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 23.84
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 23.66
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 23.53
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 23.48
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 23.14
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 23.09
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 22.91
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 22.74
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 22.74
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 22.73
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 22.73
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 22.18
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 22.18
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 21.88
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 21.77
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 21.68
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 21.42
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 21.37
Gene expression profile of multiple myeloma cell lines treated with CB-5083 20.59
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 20.57
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 20.57
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 20.22
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 20.17
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 20.16
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 20.14
Expression data from miR340 overexpressing human A549 cells 19.88
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 19.67
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 19.4
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 19.32
Differential analysis of gene regulation at transcript resolution by RNA-Seq 19.23
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 19.23
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 19.15
Global expression profiles in cardiac progenitor cells generated by ISX-9 19.15
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 19.11
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 19.01
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 19.01
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 18.88
A549 cells and MSR-A549 cells 18.85
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 18.85
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 18.71
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 18.68
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 18.57
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 18.37
Non-coding regions are the main source of tumor-specific antigens [human] 17.97
Non-coding regions are the main source of tumor-specific antigens 17.97
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 17.83
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 17.39
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 17.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 17.2
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 17.2
Depicting early human development and germ cell origin with porcine embryos 17.16
Patient-derived luminal breast cancer xenografts with progestins 17.09
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 17.09
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 17.0
IMP3 regulated gene expression in breast cancer cells 17.0
The pause-initiation limit restricts transcription activation in human cells 16.97
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 16.72
IDH3a KO RNA-seq 16.49
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 16.27
Regulation of highly expressed hCINAP on translatome 16.2
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 16.17
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 16.07
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 15.97
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 15.97
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 15.96
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 15.94
Ro60-knockout cells 15.9
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 15.68
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 15.6
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 15.57
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 15.46
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 15.4
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 15.35
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 15.35
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 15.3
Identifying the molecular mode of action of itraconazole in colorectal cancer 15.09
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 15.06
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 14.86
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 14.85
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 14.76
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 14.43
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 14.43
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 14.41
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 14.4
Hypoxic transcriptome of SQ20B human head and neck cancer cells 14.39
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 14.33
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 14.31
ChIP-seq and RNA-seq from human lymphoma cell lines 14.29
RNA-seq data from human lymphoma cell lines 14.29
Transcriptomic analyssis following EHMT1/2 inhibition 14.25
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 14.19
Gene expressions of H9s in different culture systems 14.18
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 14.13
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 14.13
The evolution of N6-methyladenosine in primates 14.07
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 14.06
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 14.06
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 13.98
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 13.94
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 13.94
Reprogrammed myeloid cell transcriptomes in NSCLC 13.93
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 13.89
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 13.88
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 13.69
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.45
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 13.41
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 13.4
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.26
Genome-wide identification of cancer-specific alternative splicing in circRNA 13.24
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 13.22
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 13.19
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 13.04
snRNAs as regulators of alternative splicing 12.98
Global Mapping of Human RNA-RNA Interactions 12.9
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 12.82
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.8
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 12.69
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.46
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 12.44
The transcriptome effect of overexpressing EZH2 in MCF7 12.28
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.28
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 12.23
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 12.23
Transcriptional profiling of microglia; current state of the art and future perspectives 12.23
Primate transcript and protein expression levels evolve under compensatory selection pressures 12.18
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 12.15
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 12.04
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 11.95
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 11.93
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 11.93
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 11.88
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 11.84
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 11.83
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 11.81
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.79
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 11.71
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 11.59
The regulartory role of ZCCHC24 in splicing machinery 11.48
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.39
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 11.38
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.34
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 11.31
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 11.31
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 11.21
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.08
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 10.99
Altering cancer transcriptomes using epigenomic inhibitors 10.99
PGE2 mediated gene expression changes in human cervical stromal cells 10.97
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 10.96
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 10.95
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 10.93
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 10.9
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 10.89
Transcriptomic and gene ontology profiling of the human corneal cell types 10.83
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 10.82
Generation of KRAS signatures using immortalized isogenic lung cells. 10.77
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 10.72
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 10.72
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 10.69
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 10.67
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.61
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 10.6
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.55
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 10.54
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 10.52
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 10.52
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.45
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.45
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 10.39
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.39
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 10.37
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 10.29
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.23
Global response to chemotherapy-induced apoptosis 10.23
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.23
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 10.22
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.21
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.21
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 10.19
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 10.19
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 10.18
Inhibition of TNBC metastasis by Gpx1 10.15
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 10.14
Toxoplasma gondii infection of human retinal pigment epithelial cells 10.1
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 10.07
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 10.06
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 10.06
IL-33 activates tumor stroma to promote intestinal polyposis 10.0
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 9.99
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 9.89
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.88
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.88
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.87
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 9.85
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 9.85
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 9.77
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 9.69
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 9.64
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.6
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 9.57
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 9.56
Identification of long noncoding RNAs regulated by p53 9.55
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.52
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 9.52
RNA-Seq with and without RNase treatment in PCa cell lines 9.49
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 9.46
Effect of nuclear IL-33 on gene expression 9.42
Finding missing proteins from epigenetically manipulated human cells 9.39
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.33
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.26
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 9.21
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 9.21
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 9.19
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 9.15
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 9.1
High-Throughput Kinetic Analysis of Fractional Killing 9.08
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 9.01
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 8.93
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 8.93
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 8.92
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.88
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 8.79
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 8.66
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 8.6
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 8.53
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 8.52
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 8.36
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 8.36
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.3
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 8.29
Effect of BMP inhibition or stimulation of primary human keratinocytes 8.29
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 8.26
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 8.26
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 8.19
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 8.11
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 8.1
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 7.98
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.92
The DPYSL2 gene connects mTOR and schizophrenia 7.91
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.89
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 7.76
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 7.65
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 7.62
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 7.61
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 7.57
Genome-wide Analysis of Chromatin Interactions in Human Cells 7.55
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.5
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 7.36
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 7.36
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 7.29
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.25
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 7.05
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.03
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.03
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 6.89
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 6.87
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.84
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 6.79
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 6.79
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 6.73
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 6.73
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 6.69
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 6.66
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.66
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.66
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.6
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.55
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 6.46
RNA-seq analysis of the human fetal kidney. 6.45
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 6.44
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 6.42
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 6.41
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 6.39
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 6.38
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 6.3
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 6.21
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 6.21
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 6.16
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 6.16
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.07
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 6.02
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 5.96
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.82
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.79
An siRNA screen identifies CHD4 as a target for epigenetic therapy 5.74
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.72
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 5.7
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 5.7
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.69
Endothelial gene expression analysis 5.66
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.66
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.65
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 5.61
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.48
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 5.45
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.39
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 5.33
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.25
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 5.25
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.23
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 5.12
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 5.07
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.93
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 4.82
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 4.8
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 4.8
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.8
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 4.73
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.65
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.65
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 4.63
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 4.63
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 4.63
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.6
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.55
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 4.5
Metastasis in triple-negative breast cancer 4.5
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 4.5
SF3B1 Degron knockdown RNA-seq 4.38
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 4.36
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 4.36
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 4.33
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 4.3
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.29
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.29
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.23
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.14
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 4.12
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.11
iPSC-Derived Cholangiocytes 4.11
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.07
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 3.94
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.91
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 3.7
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.7
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.7
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.68
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.6
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.6
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.5
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.5
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 3.47
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 3.47
Measure transcript integrity using RNA-seq data 3.41
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.36
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.33
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 3.25
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.18
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 3.04
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 2.98
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 2.98
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.98
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 2.95
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.92
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.73
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.68
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.67
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.6
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.53
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.51
Common inflammatory pathways between NEC and Crohn's disease 2.5
RNA-seq analysis upon ARID1B overexpression 2.48
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.35
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.3
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.17
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.17
Effects of transcription on genome - nuclear lamina interactions 2.17
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.06
The Genetic Landscape of Diamond-Blackfan Anemia 1.99
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.97
RNA seq comparison between scrambled and shGRP78 cells 1.96
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.96
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.94
Copper Regulation of HIF-1 Transcription Activity 1.93
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.93
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.87
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.82
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.81
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.8
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.8
Characterization of the Merkel cell carcinoma miRNome 1.77
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.76
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.74
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.74
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.74
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.72
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.63
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.63
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.62
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.62
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 1.57
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.54
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.52
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.52
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.38
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 1.38
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.28
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.25
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.24
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.23
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.23
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.17
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.16
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 1.16
RNA-sequencing in immortalized human mammary epithelial cells 1.16
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.12
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.1
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.07
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.07
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.03
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.96
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.92
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.92
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.91
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.91
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.9
6mer seed toxicity in viral microRNAs 0.82
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.77
Aneuploidy triggers an immune response 0.74
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.72
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.72
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.72
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.68
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.62
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.61
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.52
hNSCs siRNA NOVA2 0.5
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.46
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.45
A code of mono-phosphorylation modulates the function of RB. 0.43
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.33
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.27
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.2
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.2
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.17
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.13
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.11
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.11
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.11
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.11
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.1
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.09
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.07
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.06
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.0
Ribosomal protein RPL26 is the principal target of UFMylation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation